Ortho-Clinical Diagnostics, Inc., has the reagents and MTS cards specifically designed for use on Johnson & Johnson Vision blood bank analyzer, centrifuges, and incubators. The ID-MTS cards are propriety use for the Ortho-Clinical Diagnostic Ortho Vision Analyzer currently in use at CCRMC. Failing to use products such as the ID-MTS Gel cards will produce unreliable results and void the analyzer warranty. ID-MTS gel cards along with products from Ortho-Clinical Diagnostics have been implemented throughout the Blood Bank section to ensure the highest patient care delivery.
On June 9, 2015, the Board of Supervisors approved agenda item C.122 to execute a blanket purchase order (#00485) with Ortho Clinical Diagnostic, Inc. in the amount of $398,786.85 to purchase blood bank reagents and supplies for the Contra Costa Regional Medical Center (CCRMC) and the Contra Costa Health Centers, for the period July 1, 2015 through June 30, 2020.
On April 12, 2016, the Board of Supervisors approved agenda item C.58 to execute a purchase order (#03926) with Ortho Clinic Diagnostics Inc., in the amount of $124,192 for the purchase of an Ortho Vision Analyzer used in the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) for the period July 1, 2016 through June 30, 2020.
On March 31, 2020, the Board of Supervisors approved agenda item C.82 to execute an amendment to purchase order (#00485) with Orthho Clinical Diagnostic, Inc. to increase the payment limit by $140,000 to a new payment limit of $538,787 for the purchase of blood bank reagents and supplies for the Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Centers, with no change in the original term of July 1, 2015 through June 30, 2020.
Blood bank reagents and products are under Vizient GPO contract effective September 1, 2018, thru August 31, 2023, due to the propriety items strictly designed for the blood bank analyzers and equipment. Since no other reagents or MTS cards can be used with the equipment currently in the Blood Bank, a sole source justification was completed for the term through August 31, 2025.
If this purchase order is not approved, the CCRMC Blood Bank Laboratory will not be able to perform critical and lifesaving testing without the requested reagents and supplies. Additionally, use of other products will void the warranty of the equipment and skew the data provided by the instruments resulting in inaccurate data.